Osaic Holdings’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-65
| Closed | -$323 | – | 7777 |
|
|
2024
Q3 | $323 | Hold |
65
| – | – | ﹤0.01% | 7090 |
|
|
2024
Q2 | $427 | Hold |
65
| – | – | ﹤0.01% | 7025 |
|
|
2024
Q1 | $711 | Hold |
65
| – | – | ﹤0.01% | 6752 |
|
|
2023
Q4 | $873 | Sell |
65
-72
| -53% | -$1.17K | ﹤0.01% | 6794 |
|
|
2023
Q3 | $2.98K | Buy |
137
+68
| +99% | +$2.18K | ﹤0.01% | 6473 |
|
|
2023
Q2 | $2.64K | Hold |
69
| – | – | ﹤0.01% | 6562 |
|
|
2023
Q1 | $1.9K | Hold |
69
| – | – | ﹤0.01% | 6736 |
|
|
2022
Q4 | $2K | Hold |
69
| – | – | ﹤0.01% | 6769 |
|
|
2022
Q3 | $8K | Hold |
69
| – | – | ﹤0.01% | 6157 |
|
|
2022
Q2 | $12K | Sell |
69
-2
| -3% | -$422 | ﹤0.01% | 5992 |
|
|
2022
Q1 | $20K | Hold |
71
| – | – | ﹤0.01% | 5711 |
|
|
2021
Q4 | $37K | Buy |
71
+2
| +3% | +$1.44K | ﹤0.01% | 5379 |
|
|
2021
Q3 | $26K | Hold |
69
| – | – | ﹤0.01% | 5603 |
|
|
2021
Q2 | $61K | Sell |
69
-1
| -1% | -$765 | ﹤0.01% | 4896 |
|
|
2021
Q1 | $84K | Buy |
70
+69
| +6,900% | +$95.1K | ﹤0.01% | 4498 |
|
|
2020
Q4 | $1K | Sell |
1
-32
| -97% | -$46.9K | ﹤0.01% | 6328 |
|
|
2020
Q3 | $74K | Buy |
33
+32
| +3,200% | +$72.4K | ﹤0.01% | 4041 |
|
|
2020
Q2 | $2K | Buy |
+1
| New | +$2.72K | ﹤0.01% | 5859 |
|
Osaic Holdings's BIOR Position: Q4 2024 in Review
Osaic Holdings sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 65 shares — an estimated $323 sold.
Osaic Holdings first reported a position in BIOR in Q2 2020 and held it in 18 quarters. The position peaked at $84K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.
- Osaic Holdings reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Osaic Holdings sold 65 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $323.
- Osaic Holdings first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 18 quarters.
- Osaic Holdings's Biora Therapeutics, Inc. Common Stock position peaked at $84K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.